تحميل
NASDAQHealthcareMedical - Diagnostics & Research
أحدث البيانات المتاحة
620.05 US$
+8.00 US$ · +1.31%
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
الإغلاق السابق
620.05 US$
+8.00 US$ · +1.31%
قبل افتتاح السوق
620.05 US$
0.00 US$ · 0.00%
13 أكتوبر، 4:11 ص ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
نطاق اليوم
السعر الحالي 620.05 US$
نطاق 52 أسبوعًا
السعر الحالي 620.05 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
74
أقل من القيمة
المشاعر
59
مختلط
المخاطر
35
مخاطر متوسطة
الزخم
51
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
نطاق اليوم
السعر الحالي 620.05 US$
نطاق 52 أسبوعًا
السعر الحالي 620.05 US$
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
620.44 US$
ارتفاع محتمل بنسبة 0.06%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI431.46 مليون0.02%2.3 ترليون USD0.03%381.57 US$-0.10%
Vanguard Morningstar Small-Cap ETFVB312.25 مليون0.17%185.3 مليار USD0.03%288.16 US$-0.46%
Invesco S&P MidCap Quality ETFXMHQ200.42 مليون3.68%5.44 مليار USD0.30%114.19 US$-0.04%
Vanguard Morningstar Small-Cap Growth ETFVBK179.22 مليون0.39%44.7 مليار USD0.05%340.88 US$-1.12%
Vanguard Extended Market ETFVXF155.72 مليون0.16%95.4 مليار USD0.05%233.52 US$-0.63%
iShares Biotechnology ETFIBB106.8 مليون0.99%10.82 مليار USD0.44%204.26 US$-1.08%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY103.21 مليون0.40%25.82 مليار USD0.23%667.3 US$-0.38%
iShares Russell Mid-Cap Growth ETFIWP77.71 مليون0.39%20.1 مليار USD0.23%140.99 US$-1.47%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBInvesco S&P MidCap Quality ETFXMHQVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Biotechnology ETFIBBState Street SPDR S&P MIDCAP 400 ETF TrustMDYiShares Russell Mid-Cap Growth ETFIWPالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
